Apremilast: a review in psoriasis and psoriatic arthritis
ED Deeks - Drugs, 2015 - Springer
Apremilast (Otezla®) is an oral phosphodiesterase 4 inhibitor indicated for the twice-daily
treatment of adults with psoriasis and psoriatic arthritis (PsA). Its use in these patient …
treatment of adults with psoriasis and psoriatic arthritis (PsA). Its use in these patient …
Apremilast: A Review in Psoriasis and Psoriatic Arthritis.
E Deeks - Drugs, 2015 - search.ebscohost.com
Apremilast (Otezla) is an oral phosphodiesterase 4 inhibitor indicated for the twice-daily
treatment of adults with psoriasis and psoriatic arthritis (PsA). Its use in these patient …
treatment of adults with psoriasis and psoriatic arthritis (PsA). Its use in these patient …
Apremilast: A Review in Psoriasis and Psoriatic Arthritis
ED Deeks - Drugs, 2015 - infona.pl
Apremilast (Otezla®) is an oral phosphodiesterase 4 inhibitor indicated for the twice-daily
treatment of adults with psoriasis and psoriatic arthritis (PsA). Its use in these patient …
treatment of adults with psoriasis and psoriatic arthritis (PsA). Its use in these patient …
Apremilast: A Review in Psoriasis and Psoriatic Arthritis
ED Deeks - Drugs, 2015 - pubmed.ncbi.nlm.nih.gov
Apremilast (Otezla (®)) is an oral phosphodiesterase 4 inhibitor indicated for the twice-daily
treatment of adults with psoriasis and psoriatic arthritis (PsA). Its use in these patient …
treatment of adults with psoriasis and psoriatic arthritis (PsA). Its use in these patient …
Apremilast: A Review in Psoriasis and Psoriatic Arthritis.
ED Deeks - Drugs, 2015 - europepmc.org
Apremilast (Otezla (®)) is an oral phosphodiesterase 4 inhibitor indicated for the twice-daily
treatment of adults with psoriasis and psoriatic arthritis (PsA). Its use in these patient …
treatment of adults with psoriasis and psoriatic arthritis (PsA). Its use in these patient …
[引用][C] Apremilast: A Review in Psoriasis and Psoriatic Arthritis
ED Deeks - Drugs, 2015 - cir.nii.ac.jp
Apremilast: A Review in Psoriasis and Psoriatic Arthritis | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
Apremilast: A Review in Psoriasis and Psoriatic Arthritis
ED Deeks - Drugs, 2015 - search.proquest.com
Apremilast (Otezla^) is an oral phosphodiesterase 4 inhibitor indicated for the twice-daily
treatment of adults with psoriasis and psoriatic arthritis (PsA). Its use in these patient …
treatment of adults with psoriasis and psoriatic arthritis (PsA). Its use in these patient …